Patients with familial pulmonary arterial hypertension inherit heterozygous mutations of the type 2 bone morphogenetic protein (BMP) receptor BMPR2. To explore the cellular mechanisms of this disease, we evaluated the pulmonary vascular responses to chronic hypoxia in mice carrying heterozygous hypomorphic Bmpr2 mutations (Bmpr2 delta Ex2/+). These mice develop more severe pulmonary hypertension after prolonged exposure to hypoxia without an associated increase in pulmonary vascular remodeling or proliferation compared with wild-type mice. This is associated with defective endothelial-dependent vasodilatation and enhanced vasoconstriction in isolated intrapulmonary artery preparations. In addition, there is a selective decrease in hypoxia-i...
International audienceBACKGROUND: Monoallelic mutations in the gene encoding bone morphogenetic prot...
SummaryMitochondrial dysfunction, inflammation, and mutant bone morphogenetic protein receptor 2 (BM...
Background and Aims: we previously reported in studies on organoid-cultured bovine pulmonary arterie...
Pulmonary arterial hypertension (PAH) is a rare and fatal disease caused by excessive remodelling of...
Background - Pulmonary arterial hypertension (PAH) is a rare but fatal lung disease of diverse origi...
International audienceAbstract Aims BMP9 and BMP10 mutations were recently identified in patients wi...
Genetic evidence implicates the loss of bone morphogenetic protein type II receptor (BMPR-II) signal...
Hypomorphic mutations in the bone morphogenic protein receptor (BMPR2) confer a much greater risk fo...
Loss-of-function mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene have been ...
Genetic evidence implicates the loss of bone morphogenetic protein type II receptor (BMPR-II) signal...
Hypomorphic mutations in the bone morphogenic protein receptor (BMPR2) confer a much greater risk fo...
Background: Hypomorphic mutations in the bone morphogenic protein receptor (BMPR2) confer a much gre...
Background: Mutations in bone morphogenetic protein receptor type II (BMPR2) are leading to the deve...
Background:Mutations in bone morphogenetic protein receptor type II (BMPR2) are leading to the devel...
International audienceBACKGROUND: Monoallelic mutations in the gene encoding bone morphogenetic prot...
SummaryMitochondrial dysfunction, inflammation, and mutant bone morphogenetic protein receptor 2 (BM...
Background and Aims: we previously reported in studies on organoid-cultured bovine pulmonary arterie...
Pulmonary arterial hypertension (PAH) is a rare and fatal disease caused by excessive remodelling of...
Background - Pulmonary arterial hypertension (PAH) is a rare but fatal lung disease of diverse origi...
International audienceAbstract Aims BMP9 and BMP10 mutations were recently identified in patients wi...
Genetic evidence implicates the loss of bone morphogenetic protein type II receptor (BMPR-II) signal...
Hypomorphic mutations in the bone morphogenic protein receptor (BMPR2) confer a much greater risk fo...
Loss-of-function mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene have been ...
Genetic evidence implicates the loss of bone morphogenetic protein type II receptor (BMPR-II) signal...
Hypomorphic mutations in the bone morphogenic protein receptor (BMPR2) confer a much greater risk fo...
Background: Hypomorphic mutations in the bone morphogenic protein receptor (BMPR2) confer a much gre...
Background: Mutations in bone morphogenetic protein receptor type II (BMPR2) are leading to the deve...
Background:Mutations in bone morphogenetic protein receptor type II (BMPR2) are leading to the devel...
International audienceBACKGROUND: Monoallelic mutations in the gene encoding bone morphogenetic prot...
SummaryMitochondrial dysfunction, inflammation, and mutant bone morphogenetic protein receptor 2 (BM...
Background and Aims: we previously reported in studies on organoid-cultured bovine pulmonary arterie...